image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Tarsus - Forward bookings ahead 11%

July 2013

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 210p
Tarsus has announced a confident update for the period 1 January to 16 May, showing revenues up 9% on a like for like basis over last year while forward bookings for 2013 are tracking 11% ahead. Bookings for the two largest events, Dubai Airshow and Labelexpo Europe are well ahead of previous editions. In emerging markets several events were held in the Middle East, China and Turkey showing good performances and this side will be boosted by the recent acquisition of Indonesian exhibitions group, PT Infrastructure Asia. Meanwhile, in the US its medical division has grown well thanks to its education programs while Off Price in Las Vegas grew 6%. Europe (now c. 5% profit) has traded in line with expectations with Label ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X